Vince & Associates Clinical Research, a provider of early development clinical trials, has opened the Neuropsychiatric Research Center in Overland Park, Kan.

The research facility will provide study recruitment, medical management and oversight in study volunteers across a range of neuropsychiatric disorders including both acute and chronic schizophrenia.

“While Vince and Associates has been conducting clinical trials in schizophrenia over the past decade, this dedicated unit will allow us to better serve the needs of both study volunteers and our biopharmaceutical clients,” said Dr. Brad Vince, president and medical director.

Debra Kelsh, M.D., a board-certified psychiatrist and an investigator, will serve as medical director of the new Neuropsychiatric Research Center.

Subject recruitment at Vince & Associates is driven by an extensive, proprietary database of more than 40,000 verified patients and healthy normal volunteers. By conducting an in-depth medical history, Vince and Associates helps ensure an accurate estimate of study volunteers available for clinical trials. The company has full-time recruitment staff, a community outreach team and an in-house call center.